Skip to main content
logo
bioXXmed AG (FRA:T5O)
Germany flag Germany · Delayed Price · Currency is EUR
1.010
-0.020 (-1.94%)
Last updated: Sep 14, 2026, 1:25 PM CET

bioXXmed AG Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
0015618
Market Cap Growth
61.96%-95.56%-86.90%-9.91%-69.02%-70.98%
Enterprise Value
0014218
Last Close Price
1.010.116.5541.0145.52185.86

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-14.7214.7214.7214.7214.72
PS Ratio
16.411.79192.67295.19466.16412.49
PB Ratio
-274584.00-29905.002.1110.930.271.03
P/TBV Ratio
--2.1110.930.271.03

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
27.255.25167.63233.04165.61394.46

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-385000.00-385000.00-0.02-0.01
Net Debt / Equity Ratio
-181332.00-181332.00-0.80-1.29-0.090.01
Net Debt / EBITDA Ratio
-0.67-0.670.290.752.25-0.08
Net Debt / FCF Ratio
-0.54-0.540.280.832.01-
Asset Turnover
0.040.040.010.000.000.00
Quick Ratio
234.64234.643.156.6013.830.16
Current Ratio
356.12356.124.047.3614.230.38
Return on Equity (ROE)
-229.36%-229.36%-252.84%-191.41%-4.23%-20.40%
Return on Assets (ROA)
-35.44%-35.44%-93.01%-4.52%-2.58%-4.84%
Return on Capital Employed (ROCE)
-57.90%-57.90%-214.30%-136.40%-3.80%-8.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-133.07%-1221.84%-148.13%-407.77%-14.55%-22.05%
FCF Yield
-122.00%-1120.21%-136.11%-14.21%-16.03%-
Buyback Yield / Dilution
-0.00%-164.59%--27.54%-